Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias
JP diMarco,
TD Sellers,
BB Lerman,
ML Greenberg,
RM Berne,
and
L Belardinelli
Adenosine has been shown to affect both sinus node automaticity and atrioventricular (AV) nodal conduction. The effects of increasing doses of intravenous adenosine were assessed in 46 patients with supraventricular tachyarrhythmias. Adenosine reliably terminated episodes of supraventricular tachycardia in all 16 patients with AV reciprocating tachycardia, in 13 of 13 patients with AV nodal reentrant tachycardia and in 1 of 2 patients with junctional tachycardia with long RP intervals. Adenosine produced transient high grade AV block without any effect on atrial activity in six patients with intraatrial reentrant tachycardia, four patients with atrial flutter, three patients with atrial fibrillation and in single patients with either sinus node reentry or an automatic atrial tachycardia. The dose of adenosine required to terminate episodes of supraventricular tachycardia was variable (range 2 to 23 mg). Side effects were minor and of short duration. These results demonstrate that adenosine is useful for the acute therapy of supraventricular tachycardia whenever reentry through the AV node is involved. When arrhythmia termination is not affected, atrial activity may be more readily analyzed during adenosine-induced transient AV block.
This article has been cited by other articles:

|
 |

|
 |
 
H. L. Collins and S. E. DiCarlo
Acute exercise increases the ventricular arrhythmia threshold via the intrinsic adenosine receptor system in conscious hypertensive rats
Am J Physiol Heart Circ Physiol,
September 1, 2005;
289(3):
H1020 - H1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Tune, M. W. Gorman, and E. O. Feigl
Matching coronary blood flow to myocardial oxygen consumption
J Appl Physiol,
July 1, 2004;
97(1):
404 - 415.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Prystowsky, I. Niazi, A. B. Curtis, D. J. Wilber, T. Bahnson, K. Ellenbogen, A. Dhala, D. M. Bloomfield, M. Gold, A. Kadish, et al.
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510),a novel A1-adenosine receptor agonist
J. Am. Coll. Cardiol.,
September 17, 2003;
42(6):
1098 - 1102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wu, L. Belardinelli, J. A. Zablocki, V. Palle, and J. C. Shryock
A partial agonist of the A1-adenosine receptor selectively slows AV conduction in guinea pig hearts
Am J Physiol Heart Circ Physiol,
January 1, 2001;
280(1):
H334 - H343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F L. Pasini, P. Capecchi, and T Di Perri
Adenosine and chronic ischemia of the lower limbs
Vascular Medicine,
November 1, 2000;
5(4):
243 - 250.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J C Hancox, K C R Patel, and J V Jones
Antiarrhythmics---from cell to clinic: past, present, and future
Heart,
July 1, 2000;
84(1):
14 - 24.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Glatter, J. Cheng, P. Dorostkar, G. Modin, S. Talwar, M. Al-Nimri, R. J. Lee, L. A. Saxon, M. D. Lesh, and M. M. Scheinman
Electrophysiologic Effects of Adenosine in Patients With Supraventricular Tachycardia
Circulation,
March 2, 1999;
99(8):
1034 - 1040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J V De Giovanni, R A Edgar, and A Cranston
Adenosine induced transient cardiac standstill in catheter interventional procedures for congenital heart disease
Heart,
October 1, 1998;
80(4):
330 - 333.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E Jaeggi, J C Fouron, A Fournier, N van Doesburg, S P Drblik, and F Proulx
Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia
Heart,
June 1, 1998;
79(6):
582 - 587.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Kwong, J.-L. Hong, R. F. Morton, and L.-Y. Lee
Role of pulmonary C fibers in adenosine-induced respiratory inhibition in anesthetized rats
J Appl Physiol,
February 1, 1998;
84(2):
417 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. S. Randhawa Jr., R. D. Lasley, and R. M. Mentzer Jr.
Salutary effects of exogenous adenosine administration on in vivo myocardial stunning
J. Thorac. Cardiovasc. Surg.,
July 1, 1995;
110(1):
63 - 74.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. B. Conti, L. Belardinelli, D. B. Utterback, and A. B. Curtis
Endogenous Adenosine Is an Antiarrhythmic Agent
Circulation,
March 15, 1995;
91(6):
1761 - 1767.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. I. Ganz and P. L. Friedman
Supraventricular Tachycardia
N. Engl. J. Med.,
January 19, 1995;
332(3):
162 - 173.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Getschman, A. M. Dietrich, W. H. Franklin, and H. D. Allen
Intraosseous Adenosine: As Effective as Peripheral or Central Venous Administration?
Arch Pediatr Adolesc Med,
June 1, 1994;
148(6):
616 - 619.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Brodsky, B. J. Allen, J. A. Grimes, and C. Gold
Enhanced Atrioventricular Conduction during Atrial Flutter after Intravenous Adenosine
N. Engl. J. Med.,
January 27, 1994;
330(4):
288 - 289.
[Full Text]
|
 |
|

|
 |

|
 |
 
E. S. W. Ben-Sorek and J. Wiesel
Ventricular Fibrillation Following Adenosine Administration: A Case Report
Arch Intern Med,
December 13, 1993;
153(23):
2701 - 2702.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Adult Advanced Cardiac Life Support
JAMA,
October 28, 1992;
268(16):
2199 - 2241.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vatz, S. C. Hammill, and D. Cooke
Radiofrequency Catheter Ablation of Aberrant Conducting Pathways of the Heart
JAMA,
October 21, 1992;
268(15):
2091 - 2098.
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Rankin and B. A. McGovern
Adenosine or Verapamil for the Acute Treatment of Supraventricular Tachycardia?
Ann Intern Med,
March 15, 1991;
114(6):
513 - 515.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. DiMarco, W. Miles, M. Akhtar, S. Milstein, A. D. Sharma, E. Platia, B. McGovern, M. M. Scheinman, and W. C. Govier
Adenosine for Paroxysmal Supraventricular Tachycardia: Dose Ranging and Comparison with Verapamil: Assessment in Placebo-Controlled, Multicenter Trials
Ann Intern Med,
July 15, 1990;
113(2):
104 - 110.
[Abstract]
[PDF]
|
 |
|
|